N-(2-oxo-1H-pyrimidin-6-yl)benzamide

We are N-(2-oxo-1H-pyrimidin-6-yl)benzamide CAS:26661-13-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(2-oxo-1H-pyrimidin-6-yl)benzamide
CAS.NO:26661-13-2
Synonyms:N-(2-oxohydropyrimidin-4-yl)benzamide
N-benzoylcytosine
Molecular Formula:C11H9N3O2
Molecular Weight:215.20800
 
Physical and Chemical Properties:
Density:1.33
Melting point:>300ºC
Index of Refraction:1.652
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥98.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:N4-Benzoylcytosine is a reactant in the synthesis of 1',2'-cyclopentyl nucleosides as potential antiviral agents.

N-(2-oxo-1H-pyrimidin-6-yl)benzamide


Related News: We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.5-(Trifluoromethyl)pyridine-2-carboxylic acid We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.4-bromo-9,9'-spirobi[fluorene] CAS:1161009-88-6 Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.1141-23-7 Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.

Related Products
Product Name
S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate View Details
Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-carboxylate View Details
Tetraethylammonium bromide View Details
3-Fluorobenzotrifluoride manufacturer methyl 3-isocyanatosulfonylthiophene-2-carboxylate manufacturer N-methylprop-2-yn-1-amine manufacturer 3-bromo-9,9-dimethyl-9H-fluorene manufacturer 4-Fluoro-2-methoxy-5-nitroaniline manufacturer